AH
ROIV icon

Andreas Halvorsen’s Roivant Sciences ROIV Stock Holding History

Andreas Halvorsen’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$222M Sell
6,271,467
-380,981
-6% -$11.3M 0.63% 52
2026
Q1 		$184M Buy
6,652,448
+209,257
+3% +$5.38M 0.52% 52
2025
Q4 		$140M Sell
6,443,191
-17,151,640
-73% -$338M 0.37% 62
2025
Q3 		$357M Sell
23,594,831
-10,642,948
-31% -$132M 0.93% 45
2025
Q2 		$386M Sell
34,237,779
-11,775,973
-26% -$128M 1.12% 35
2025
Q1 		$464M Sell
46,013,752
-1,796,208
-4% -$19.4M 1.48% 27
2024
Q4 		$566M Sell
47,809,960
-6,289,106
-12% -$74.4M 1.83% 20
2024
Q3 		$624M Sell
54,099,066
-15,056,780
-22% -$171M 2.28% 17
2024
Q2 		$731M Sell
69,155,846
-213,115
-0.3% -$2.34M 2.81% 12
2024
Q1 		$731M Hold
69,368,961
– – 2.72% 10
2023
Q4 		$779M Sell
69,368,961
-4,065,340
-6% -$39.6M 2.85% 11
2023
Q3 		$858M Sell
73,434,301
-1,804,399
-2% -$20.4M 3.48% 11
2023
Q2 		$758M Sell
75,238,700
-13,000,000
-15% -$116M 3.1% 7
2023
Q1 		$651M Hold
88,238,700
– – 3.06% 13
2022
Q4 		$705M Hold
88,238,700
– – 3.53% 7
2022
Q3 		$284M Hold
88,238,700
– – 1.31% 29
2022
Q2 		$359M Hold
88,238,700
– – 1.64% 25
2022
Q1 		$436M Hold
88,238,700
– – 1.76% 18
2021
Q4 		$889M Buy
+88,238,700
New +$734M 2.56% 9

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Andreas Halvorsen's ROIV Position: Q2 2026 in Review

Andreas Halvorsen reduced its Roivant Sciences (ROIV) stake by 5.7% in Q2 2026, selling an estimated $11.3M and leaving 6,271,467 shares worth $222M. The position accounts for 0.63% of the portfolio, ranked #52.

Andreas Halvorsen first reported a position in ROIV in Q4 2021 and has held it in 19 quarters since. The position peaked at $889M in Q4 2021. 495 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Andreas Halvorsen held 6,271,467 shares of Roivant Sciences worth $222M as of Q2 2026.
  • Andreas Halvorsen sold 380,981 Roivant Sciences shares in Q2 2026, an estimated $11.3M.
  • Roivant Sciences made up 0.63% of Andreas Halvorsen's portfolio in Q2 2026, its #52 holding.
  • Andreas Halvorsen first reported a position in Roivant Sciences in Q4 2021 and has held it in 19 quarters since.
  • Andreas Halvorsen's Roivant Sciences position peaked at $889M in Q4 2021.
  • 495 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Viking Global Investors's 13F filing for Q2 2026, filed 14 Aug 2026.